Buscar resultados de ensayos clínicos
Leukemia, Hairy Cell - 25 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia Condición: Leukemia, Hairy Cell Fecha: 2013-04-09 Intervenciones:
|
Recruiting |
Nombre del estudio: Therapy Optimisation for the Treatment of Hairy Cell Leukemia Condición: Hairy Cell Leukemia Fecha: 2014-04-30 Intervenciones: Drug: Cladribine s.c. injection, HCL treatment Patients with hairy cell leukemia and the need for treatm |
Terminated |
Nombre del estudio: Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia Condición: Hairy Cell Leukemia Fecha: 2009-06-17 Intervenciones: Drug: BL22 (CAT-3888) 30 micrograms/kg intravenous over 30 minutes every other day (QOD) on days 1, 3, 5 |
Active, not recruiting |
Nombre del estudio: LMB-2 to Treat Hairy Cell Leukemia Condición: Hairy Cell Leukemia Fecha: 2006-05-03 Intervenciones: Drug: Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin LMB-2 Infusion: 40 micro-g/Kg will be infused in 50 ml of 0. |
Recruiting |
Nombre del estudio: Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia Condición: Hairy Cell Leukemia Fecha: 2010-01-29 Intervenciones:
|
Completed |
Nombre del estudio: Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective Study Condición: Hairy-cell Leukemia Fecha: 2016-08-25 Intervenciones: Other: Data collection |
Completed |
Nombre del estudio: A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia Condición: Hairy Cell Leukemia Fecha: 1999-11-03 Intervenciones: Drug: Roferon-A |
Active, not recruiting |
Nombre del estudio: BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia Condición: Hairy Cell Leukemia Fecha: 2012-10-17 Intervenciones: Drug: Vemurafenib Patients will receive vemurafenib at a dose of 960mg orally b.i.d. continuously in cyc |
Recruiting |
Nombre del estudio: Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia Condición:
|
Recruiting |
Nombre del estudio: Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia Condición: Hairy Cell Leukemia Fecha: 2009-06-17 Intervenciones:
|